Military Invests $27M To Develop New Class Of Psychedelics-Inspired Drugs
The successful use of controlled substances such as ketamine and psilocybin mushrooms to treat mental health issues like depression and anxiety has ushered in a new era of interest in psychedelic drugs. But for researchers and clinicians eager to expand such therapies, an obvious question remains: Does treatment with psychedelics necessarily require a psychedelic experience? … Continue reading Military Invests $27M To Develop New Class Of Psychedelics-Inspired Drugs
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed